Subcutaneous Interferon-β1a Does Not Increase the Risk of Stroke in Patients with Multiple Sclerosis: Analysis of Pooled Clinical Trials and Post-Marketing Surveillance
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1865-8652
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Subcutaneous Interferon-β1a Does Not Increase the Risk of Stroke in Patients with Multiple Sclerosis: Analysis of Pooled Clinical Trials and Post-Marketing Surveillance ; volume:35 ; number:11 ; day:25 ; month:9 ; year:2018 ; pages:2041-2053 ; date:11.2018
Advances in therapy ; 35, Heft 11 (25.9.2018), 2041-2053, 11.2018
- Urheber
-
Sabidó, Meritxell
Venkatesh, Saritha
Hayward, Brooke
Aldridge, Julie
Gillett, Alan
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12325-018-0790-1
- URN
-
urn:nbn:de:101:1-2018122700191711976694
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sabidó, Meritxell
- Venkatesh, Saritha
- Hayward, Brooke
- Aldridge, Julie
- Gillett, Alan
- SpringerLink (Online service)
Ähnliche Objekte (12)
Safety of nivolumab monotherapy in five cancer types: pooled analysis of post-marketing surveillance in Japan
Post-marketing surveillance of anti-malarial medicines used in Malawi
Post-marketing safety surveillance and re-evaluation of Xueshuantong injection
Post-Marketing Safety Surveillance for the Adjuvanted Recombinant Zoster Vaccine: Methodology
An Evaluation of “Drug Ineffective” Postmarketing Reports in Drug Safety Surveillance
Safety of Brexanolone in Adults with Postpartum Depression: Postmarketing Surveillance Data
Worldwide, 3-Year, Post-Marketing Surveillance Experience with Tofacitinib in Rheumatoid Arthritis
Post-marketing Surveillance of a Quadrivalent Influenza Vaccine (Vaxigrip Tetra) in South Korea
Long-term safety of secukinumab in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis: integrated pooled clinical trial and post-marketing surveillance data
Postmarketing surveillance of safety and effectiveness of etanercept in Japanese patients with rheumatoid arthritis
Post-marketing surveillance of anticancer drugs using natural language processing of electronic medical records
Isatuximab with pomalidomide-dexamethasone in relapsed/refractory multiple myeloma: post-marketing surveillance in Japan
Safety of nivolumab monotherapy in five cancer types: pooled analysis of post-marketing surveillance in Japan
Post-marketing surveillance of anti-malarial medicines used in Malawi
Post-marketing safety surveillance and re-evaluation of Xueshuantong injection
Post-Marketing Safety Surveillance for the Adjuvanted Recombinant Zoster Vaccine: Methodology
An Evaluation of “Drug Ineffective” Postmarketing Reports in Drug Safety Surveillance
Safety of Brexanolone in Adults with Postpartum Depression: Postmarketing Surveillance Data
Worldwide, 3-Year, Post-Marketing Surveillance Experience with Tofacitinib in Rheumatoid Arthritis
Post-marketing Surveillance of a Quadrivalent Influenza Vaccine (Vaxigrip Tetra) in South Korea
Long-term safety of secukinumab in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis: integrated pooled clinical trial and post-marketing surveillance data
Postmarketing surveillance of safety and effectiveness of etanercept in Japanese patients with rheumatoid arthritis
Post-marketing surveillance of anticancer drugs using natural language processing of electronic medical records
Isatuximab with pomalidomide-dexamethasone in relapsed/refractory multiple myeloma: post-marketing surveillance in Japan
Safety of nivolumab monotherapy in five cancer types: pooled analysis of post-marketing surveillance in Japan
Post-marketing surveillance of anti-malarial medicines used in Malawi
Post-marketing safety surveillance and re-evaluation of Xueshuantong injection
Post-Marketing Safety Surveillance for the Adjuvanted Recombinant Zoster Vaccine: Methodology
An Evaluation of “Drug Ineffective” Postmarketing Reports in Drug Safety Surveillance
Safety of Brexanolone in Adults with Postpartum Depression: Postmarketing Surveillance Data
Worldwide, 3-Year, Post-Marketing Surveillance Experience with Tofacitinib in Rheumatoid Arthritis
Post-marketing Surveillance of a Quadrivalent Influenza Vaccine (Vaxigrip Tetra) in South Korea
Long-term safety of secukinumab in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis: integrated pooled clinical trial and post-marketing surveillance data
Postmarketing surveillance of safety and effectiveness of etanercept in Japanese patients with rheumatoid arthritis
Post-marketing surveillance of anticancer drugs using natural language processing of electronic medical records